Cours Neurokine Pharmaceuticals Inc Other OTC
Actions
CAC611561100
Recherche biotechnologique et médicale
Cours en clôture
Autres places de cotation
|
||
- USD | - |
CA 2022 | - | CA 2023 | - | Capitalisation | 13,32 M 12,24 M |
---|---|---|---|---|---|
Résultat net 2022 | -12 M -11,03 M | Résultat net 2023 | -9 M -8,27 M | VE / CA 2022 | - |
Dette nette 2022 | 139 k 128 k | Dette nette 2023 | 71,69 k 65,91 k | VE / CA 2023 | - |
PER 2022 |
-1,26
x | PER 2023 |
-1,36
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 77,36% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17/09/07 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 26/12/10 |
Chief Operating Officer | 67 | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17/09/07 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 21/01/20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 05/02/15 |
Varia. 1 janv. | Capi. | |
---|---|---|
-3,46% | 102 Md | |
+1,41% | 96,09 Md | |
+2,13% | 22,28 Md | |
-15,84% | 21,4 Md | |
-9,21% | 18,14 Md | |
-39,98% | 17,02 Md | |
-14,65% | 16,09 Md | |
+4,39% | 13,83 Md | |
+31,35% | 11,97 Md |
- Bourse
- Actions
- Action BETRF
- Action